Skip to content

Inosine Energy Expenditure Study

Randomized Cross-over Trial to Investigate the Effect of Inosine on Human Energy Expenditure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04476238
Acronym
InoBAT
Enrollment
8
Registered
2020-07-20
Start date
2022-02-28
Completion date
2023-04-30
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Energy expenditure, metabolism, inosine

Brief summary

Investigators want to test whether the intake of the nucleoside inosine increases the human energy expenditure. Inosine occurs as a metabolic intermediate in the human body and is sometimes taken as a dietary supplement by athletes. For this purpose, investigators will measure the basal metabolic rate by indirect calorimetry. Study participants will then take inosine dissolved in water or placebo and energy expenditure will be assessed again.

Interventions

DIETARY_SUPPLEMENTInosine

2 grams of inosine dissolved in 250 ml water taken by mouth

OTHERPlacebo

250 ml water taken by mouth

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male volunteers * BMI between 18-27 kg/m2 * Age between 18 and 40 years

Exclusion criteria

* Chronic concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, diabetes mellitus), * Known or suspected non-compliance, drug or alcohol abuse, * Inability to follow the procedures of the study * Participation in another study with investigational drug within the 30 days preceding and during the present study, * Previous enrolment into the current study, * Enrolment of the investigator, his/her family members, employees and other dependent persons, * Thyroid disorders

Design outcomes

Primary

MeasureTime frameDescription
resting energy expenditure after Inosineone hour after oral intake of inosineresting energy expenditure (REE) assessed by indirect calorimetry after oral intake of two grams of inosine as compared to placebo

Secondary

MeasureTime frameDescription
Change in energy expenditureone hour after oral intake of inosine\- Difference in EE between baseline measurement and measurement one hour after administration of inosine or control, respectively, at each study visit.
Change in Respiratory Quotientone hour after oral intake of inosine\- Respiratory quotient (RQ) as an indicator of substrate oxidation one hour after oral intake of two grams of inosine
Serum inosine level0 hours, 1 hour, 2 hoursSerum inosine levels after ingestion of inosine

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026